Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bicalutamide analogs or (S)-bicalutamide as exocytosis activating compounds for use in the treatment of a lysosomal storage disorder or glycogenosis

Bicalutamide analogs or (S)-bicalutamide as exocytosis activating compounds for use in the treatment of a lysosomal storage disorder or glycogenosis

US Patent 11571407 · Granted Feb 7, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Peptides for inhibiting cholinergic calcitonin gene-related peptide (CGRP) and a2025
Cortistatin analogues for the treatment of inflammatory and/or immune diseases2025
Cortistatin analogues for the treatment of inflammatory and/or immune diseases2025
Peptides having inhibitory activity on muscarinic receptor M32024
Compounds useful for the treatment and/or care of the skin, hair, nails and/or m2024
TRPV1 modulator compounds2022
TRPM8 receptor agonist compounds and uses thereof2021
Compounds useful in the treatment and/or care of the skin, hair, nails, and/or m2020
Exopolysaccharide for the treatment and/or care of the skin, culture media and c2019
Cosmetic composition containing halomonas ferment extract, and use thereof2019
Cosmetic and/or pharmaceutical composition containing a bacterial extracellular 2019
Ferment extract of a bacterial strain for the increase of adiponectin levels2018